Why does Bolt.new not work for production medical apps?

Bolt.new lacks a Business Associate Agreement, which is the contract that legally permits a vendor to handle Protected Health Information on a covered entity's behalf. Without a signed BAA, any patient identifier pasted into the prompt window or stored on the default Netlify deploy sits outside HIPAA protections. The platform is well suited to design and prototyping with synthetic data, then porting the code to a HIPAA-eligible production stack.

Can I use Bolt.new with the Supabase HIPAA add-on directly?

The Supabase add-on covers the database side once the BAA is signed and the High Compliance flag is on. It does not cover the Bolt.new editor, the StackBlitz runtime, or the LLM that processes your prompts. A practical workflow is to develop on synthetic data inside Bolt.new, then deploy the same codebase to a HIPAA-eligible Supabase organization from a separate CI runner outside the StackBlitz environment.

Does pasting a fake patient name into a Bolt.new prompt still count as PHI?

Synthetic test data is safe if it cannot be linked back to a real person. A fabricated name, a fake date of birth, and made up identifiers stay outside HIPAA scope, which is why most healthcare teams keep a stable seed dataset for prototyping. Real records from a clinic, even with the name redacted, can still be re-identifiable and remain PHI under HHS guidance.

Is there a faster way to verify a Bolt.new medical build before submitting?

A pre-submission scan against OWASP MASVS catches the storage, network, and crypto findings most often flagged for health apps: PHI in localStorage, missing TLS pinning where required, weak key derivation, and audit log gaps. Running the compiled IPA or APK through a static analyzer before upload surfaces the same patterns reviewers and regulators look for, without waiting for a formal rejection notice.

Is Bolt.new safe for medical app development?

A founder uses Bolt.new to prototype a patient intake app over a weekend. By Monday the app reads, writes, and renders what looks like real medical data, and the question stops being can it run and starts being can it ship. Medical app development sits inside the most regulated software category that mobile stores accept, and the safe answer to is Bolt.new ready for that is more granular than yes or no.

Short answer

Bolt.new is safe enough for medical app prototyping and unsafe for production medical apps without a redesigned compliance perimeter. The platform itself does not sign a Business Associate Agreement, so any Protected Health Information that flows through the generated build forces you to swap the default backend, authentication, and hosting for vendors that do sign BAAs. The generated source code also needs a manual audit against the HIPAA Security Rule and OWASP MASVS before submission to App Store or Google Play.

What you should know

Bolt.new does not publish a BAA. StackBlitz, the parent company, has no public Business Associate Agreement on any plan, which rules out sending real PHI through the editor or its hosted runtime.
The default stack is Supabase plus Netlify. Both can host healthcare data, but only on specific paid plans with the HIPAA add-on enabled and signed BAAs in place.
Prompts are sent to a third-party LLM. Pasting a real patient record into the prompt window transmits PHI to the model provider before any code is generated or deployed.
Generated code has no PHI awareness. The AI does not label fields, scope access, or audit reads by default; that work sits on the developer.
App Store and Google Play apply tighter rules to health apps. App Review Guideline 1.4 and the Play Health Apps Policy both require accurate medical claims, valid certifications where relevant, and clear data handling disclosures.
The compiled build still ships under your developer account. You carry the regulator-facing risk, not the AI builder.

How does Bolt.new actually handle code and data for a medical app?

The short answer is that Bolt.new is a browser-based coding agent that drafts a full-stack web or mobile-web app from natural language prompts, then deploys it to a hosting provider you select.

Under the hood, Bolt.new runs inside StackBlitz WebContainers, which means the project files and runtime live inside the browser tab while the prompt itself is sent to an LLM hosted by Anthropic. The default integrations include Supabase for the database, Netlify for hosting, and Stripe for billing. When you describe a patient app, the AI scaffolds tables, an authentication flow, and a React or Next.js front end that talks to Supabase.

The mechanism matters because each layer of the stack has its own compliance posture. Bolt.new and StackBlitz handle the editor and runtime. Supabase handles the database and storage. Netlify handles the deployment. Anthropic handles the model. For a medical app, every one of these vendors must either be out of scope for PHI or covered by a Business Associate Agreement, per the HIPAA Security Rule.

The limit is that Bolt.new does not coordinate this for you. There is no single switch that turns a Bolt.new project into a HIPAA-compliant medical app; each vendor has to be addressed separately, and the application code produced by the AI has to be audited against the technical safeguards in §164.312 of the rule.

Can Bolt.new sign a Business Associate Agreement?

The short answer is no, not at present.

A Business Associate Agreement is the contractual mechanism that makes any vendor handling PHI on a covered entity's behalf legally responsible for HIPAA's Security and Privacy Rules. The HHS guidance on business associates is clear that a BAA must be in place before the vendor sees PHI, and the absence of one is itself a violation.

StackBlitz, the company behind Bolt.new, does not advertise a BAA on any pricing tier as of May 2026. Their terms cover general software-as-a-service hosting, not protected health information. Pasting a real patient name, diagnosis, or identifier into the Bolt.new prompt window transmits that data to StackBlitz infrastructure and to Anthropic's models, both of which sit outside any BAA you might hold with a downstream vendor.

A workable pattern is to keep Bolt.new on synthetic data only during the design phase, then port the generated codebase out of the StackBlitz runtime and host it on infrastructure where every party in the data path is covered by a BAA. For most teams that means running the production build on a HIPAA-eligible Vercel, AWS, or Google Cloud account and a Supabase organization with the HIPAA add-on enabled.

Which parts of the default stack can be made HIPAA-eligible?

The short answer is that Supabase, Vercel, and AWS each have a documented HIPAA path, while Bolt.new's default Netlify deployment does not.

Supabase documents a HIPAA add-on that is available on the Team plan and above. Once the add-on is enabled and the BAA is signed, projects can be marked as High Compliance and Supabase runs continual checks against settings like Row Level Security, encrypted columns, and audit logging. Without the add-on, a Supabase project is not approved to hold PHI, regardless of whether the schema looks correct.

Netlify, the default hosting target Bolt.new offers, has no public BAA. Vercel offers HIPAA-eligible hosting on its Enterprise plan with a signed BAA in place. AWS Amplify, Cloudflare Workers, and Google Cloud Run all expose HIPAA-eligible configurations under their respective BAA programs.

Component	HIPAA path	Required to handle PHI
Bolt.new editor and runtime	None advertised	Restrict to synthetic data only
Anthropic LLM (prompts)	Zero Data Retention BAA on enterprise contracts	Do not paste PHI into prompts
Supabase database	HIPAA add-on on Team plan with BAA	Enable add-on, sign BAA, turn on RLS
Netlify hosting	None advertised	Migrate to Vercel Enterprise, AWS, or GCP
Stripe payments	Stripe signs a BAA for processing health data	Sign BAA, restrict metadata fields
Sentry or PostHog telemetry	Both offer BAAs on paid plans	Sign BAA, scrub PHI from event payloads

The practical implication is that a Bolt.new-generated medical app is closer to a starting skeleton than a finished product. Each row in that table is a separate procurement step the AI cannot complete on your behalf.

What does the generated source code miss that medical apps need?

The short answer is the auditable bits: minimum necessary access, audit logging, encryption choices that survive a regulator review, and field-level PHI tagging.

The HIPAA Security Rule, in §164.312, names four technical safeguards: access control, audit controls, integrity, and transmission security. Bolt.new can produce authentication and basic role checks if you ask for them, but a generated app rarely includes per-record access logs, encrypted column types for sensitive fields, integrity hashes on stored documents, or session timeout patterns sized for a clinical context.

The OWASP MASVS is the parallel checklist for the compiled mobile build. Health apps lean heavily on MASVS-STORAGE (no PHI in plaintext logs, caches, or backups), MASVS-CRYPTO (correct key handling), MASVS-AUTH (session, biometric, and MFA), MASVS-NETWORK (TLS pinning where appropriate), and MASVS-PRIVACY (consent, minimization). Bolt.new produces a working app; it does not produce a MASVS-aligned one without explicit prompting and a post-generation audit.

Two patterns the AI tends to get wrong by default are placing API keys in client-side environment variables and storing PHI inside browser localStorage. Both are common in scaffolded Bolt projects, both fail MASVS-STORAGE on review, and both are recoverable only with a deliberate refactor.

How do App Store and Google Play treat medical apps built this way?

The short answer is that both stores apply extra scrutiny to health apps regardless of how the code was written, and an AI-generated build is reviewed against the same standard as a hand-coded one.

App Review Guideline 1.4 covers medical apps and requires that any diagnostic, dosage, or treatment claim is backed by valid clinical evidence and clearly labeled. Guideline 5.1.3 adds health-specific data handling rules. The reviewer does not care that the source code came from Bolt.new; they care that the data flow, the privacy nutrition labels in App Store Connect, and the in-app claims match what you wrote on the listing.

The Google Play Health Apps Policy requires accurate disclosure of data handling under the Data Safety form, restricts personal health information sharing without explicit consent, and applies extra rules for apps that connect to wearable health data or claim diagnostic function.

For builders who want an external read of a compiled medical build before submission, PTKD.com (https://ptkd.com) is one of the platforms focused on pre-submission scanning of APK, AAB, and IPA files against OWASP MASVS controls, with a view to the kinds of storage and network findings reviewers and regulators tend to surface.

The practical takeaway is that a medical app built with Bolt.new can pass review, but the path runs through a manual audit, a documented HIPAA program, and a tested production stack, not through the AI alone.

What to watch out for

The first trap is using real patient data in Bolt.new prompts to explain the workflow. Even one paste sends PHI to StackBlitz and the model provider outside any BAA. Build a synthetic dataset before the first prompt and stay on it for the entire design phase.

The second trap is shipping the default Supabase project without the HIPAA add-on. The schema, the keys, and the URL look identical to a HIPAA-eligible project, but Supabase states explicitly that PHI on a non-add-on project violates the terms of service. Verify the add-on is active on the production organization before the first real user signs up.

The third trap is leaving the Netlify deploy live. Bolt.new connects to Netlify with one click, and many founders forget that the prototype URL is the same URL their first beta tester uses. Migrate to a hosting provider with a signed BAA before any tester account is created against real data.

The fourth trap is treating the AI's TypeScript output as a finished implementation. Generated code tends to log request bodies, expose service-role keys to the client, and skip audit tables. A line-by-line review for these patterns is the minimum before a clinical workflow runs.

Key takeaways

Bolt.new is a fast prototype tool for medical app design, not a HIPAA-ready production environment; the platform does not publish a Business Associate Agreement.
A safe production path swaps the default Bolt stack for vendors that do sign BAAs: Supabase with the HIPAA add-on, Vercel Enterprise or AWS for hosting, Stripe for payments.
The generated source code needs a manual review against the HIPAA Security Rule's §164.312 technical safeguards and OWASP MASVS before any PHI flows.
App Review Guideline 1.4 and the Play Health Apps Policy apply the same scrutiny to AI-generated medical builds as to hand-coded ones; the listing, the privacy labels, and the data flow have to match.
Some teams outsource the binary level audit of a compiled medical build to platforms like PTKD.com (https://ptkd.com), reading the APK or IPA against OWASP MASVS before App Store or Google Play submission rather than discovering a finding in review.